Comparative real-world safety profiles of selective β1-adrenergic receptor blockers

Weijie Ren, Haosen Zhao, Zhenzhong Wang, Jixin Li, Zelong Niu, Ruiling Zhou, Zhijie Cui, Zezhou Zhang, Peili Wang · 2026

Read Comparative real-world safety profiles of selective β1-adrenergic receptor blockers by Weijie Ren, Haosen Zhao, Zhenzhong Wang, Jixin Li, Zelong Niu, Ruiling Zhou, Zhijie Cui, Zezhou Zhang, Peili Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13619275.txt.

Description

Weijie Ren and co-authors compared in 2026 the real-world safety records of three widely used beta blockers. Metoprolol, bisoprolol, and atenolol anchor care for hypertension, coronary disease, and heart failure, yet trials reveal only part of their risk picture. The team mined two national adverse event systems, American and Canadian, covering reports from 2004 to mid-2025. Statistical disproportionality methods flagged which harms cluster with which drug.

All three shared a core pattern: slow heart rate, conduction trouble, heart failure, and unstable blood pressure. Each also carried its own signature. Metoprolol reports leaned toward a dangerous combined syndrome and mental health events. Bisoprolol leaned toward salt imbalance and kidney injury. Atenolol leaned toward pressure swings and interaction effects. Sex-split views added further differences for two drugs. The authors offer the profiles for more careful prescribing.

Catalog record

CREATORWeijie Ren, Haosen Zhao, Zhenzhong Wang, Jixin Li, Zelong Niu, Ruiling Zhou, Zhijie Cui, Zezhou Zhang, Peili Wang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13619275

Browse the full library · About the Tower of Babel